Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal dose of dexmedetomidine combined with ropivacaine for TAP block in cesarean section analgesia
ChiCTR2300068207Phase 4Completed
- Sponsor
- Panzhihua Central Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in postoperative pain (5 arms), sponsored by Panzhihua Central Hospital. Primary endpoints: First rescue analgesia time and Total consumption of sufentanil. Started Jan 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300068207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068207.